{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:25:29Z","timestamp":1793165129948,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Therapeutic drug monitoring (TDM) of aminoglycosides and vancomycin is used to prevent oto- and nephrotoxicity in neonates. Analytical and nonanalytical factors potentially influence dosing recommendations. This study aimed to determine the impact of analytical variation (imprecision and bias) and nonanalytical factors (accuracy of drug administration time, use of non-trough concentrations, biological variation, and dosing errors) on neonatal antimicrobial dosing recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Published population pharmacokinetic models and the Australasian Neonatal Medicines Formulary were used to simulate antimicrobial concentration\u2013time profiles in a virtual neonate population. Laboratory quality assurance data were used to quantify analytical variation in antimicrobial measurement methods used in clinical practice. Guideline-informed dosing recommendations based on drug concentrations were applied to compare the impact of analytical variation and nonanalytical factors on antimicrobial dosing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Analytical variation caused differences in subsequent guideline-informed dosing recommendations in 9.3\u221212.1% (amikacin), 16.2\u221219.0% (tobramycin), 12.2\u221245.8% (gentamicin), and 9.6\u221219.5% (vancomycin) of neonates. For vancomycin, inaccuracies in drug administration time (45.6%), use of non-trough concentrations (44.7%), within-subject biological variation (38.2%), and dosing errors (27.5%) were predicted to result in more dosing discrepancies than analytical variation (12.5%). Using current analytical performance specifications, tolerated dosing discrepancies would be up to 14.8% (aminoglycosides) and 23.7% (vancomycin).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although analytical variation can influence neonatal antimicrobial dosing recommendations, nonanalytical factors are more influential. These result in substantial variation in subsequent dosing of antimicrobials, risking inadvertent under- or overexposure. Harmonization of measurement methods and improved patient management systems may reduce the impact of analytical and nonanalytical factors on neonatal antimicrobial dosing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvad036","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T20:45:27Z","timestamp":1682714727000},"page":"637-648","source":"Crossref","is-referenced-by-count":6,"title":["Analytical and Non-Analytical Variation May Lead to Inappropriate Antimicrobial Dosing in Neonates: An In Silico Study"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8508-8990","authenticated-orcid":false,"given":"Thi A","family":"Nguyen","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranita","family":"Kirubakaran","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital , Sydney, NSW , Australia"},{"name":"Seberang Jaya Hospital , Penang , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley B","family":"Schultz","sequence":"additional","affiliation":[{"name":"UniSA: Clinical & Health Sciences, University of South Australia , Adelaide, SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherilyn","family":"Wong","sequence":"additional","affiliation":[{"name":"UniSA: Clinical & Health Sciences, University of South Australia , Adelaide, SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E","family":"Reuter","sequence":"additional","affiliation":[{"name":"UniSA: Clinical & Health Sciences, University of South Australia , Adelaide, SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"McMullan","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Sydney Children\u2019s Hospital , Randwick, NSW , Australia"},{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Bolisetty","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Campbell","sequence":"additional","affiliation":[{"name":"NSW Health Pathology, Department of Chemical Pathology, Prince of Wales Hospital , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R","family":"Horvath","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"},{"name":"NSW Health Pathology, Department of Chemical Pathology, Prince of Wales Hospital , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-587X","authenticated-orcid":false,"given":"Sophie L","family":"Stocker","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health, The University of Sydney , Sydney, NSW , Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2023060101575740300_hvad036-B1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Every newborn: progress, priorities, and potential beyond survival","volume":"384","author":"Lawn","year":"2014","journal-title":"Lancet"},{"key":"2023060101575740300_hvad036-B2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(14)70804-7","article-title":"Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis","volume":"14","author":"Seale","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2023060101575740300_hvad036-B3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1542\/peds.2012-0541","article-title":"Management of neonates with suspected or proven early-onset bacterial sepsis","volume":"129","author":"Polin","year":"2012","journal-title":"Pediatrics"},{"key":"2023060101575740300_hvad036-B4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2021.08.075","article-title":"Medication use in the neonatal intensive care unit and changes from 2010 to 2018","volume":"240","author":"Stark","year":"2021","journal-title":"J Pediatr"},{"key":"2023060101575740300_hvad036-B5","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023060101575740300_hvad036-B6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00228-008-0599-y","article-title":"Clinical pharmacokinetics of aminoglycosides in the neonate: a review","volume":"65","author":"Pacifici","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"2023060101575740300_hvad036-B7","author":"European Medicines Agency"},{"key":"2023060101575740300_hvad036-B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"Roberts","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"2023060101575740300_hvad036-B9","doi-asserted-by":"crossref","first-page":"e77169","DOI":"10.1371\/journal.pone.0077169","article-title":"Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"2023060101575740300_hvad036-B10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkg296","article-title":"Evaluation of commercial assays for vancomycin and aminoglycosides in serum: a comparison of accuracy and precision based on external quality assessment","volume":"52","author":"Wilson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2023060101575740300_hvad036-B11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/0004563214520749","article-title":"Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice","volume":"51","author":"Cho","year":"2014","journal-title":"Ann Clin Biochem"},{"key":"2023060101575740300_hvad036-B12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/FTD.0000000000000752","article-title":"Evaluation of assays to measure aminoglycosides in serum: comparison of accuracy and precision based on external quality assessment","volume":"42","author":"Li","year":"2020","journal-title":"Ther Drug Monit"},{"key":"2023060101575740300_hvad036-B13","doi-asserted-by":"crossref","first-page":"1974972","DOI":"10.1155\/2016\/1974972","article-title":"Different vancomycin immunoassays contribute to the variability in vancomycin trough measurements in neonates","volume":"2016","author":"Samardzic","year":"2016","journal-title":"Biomed Res Int"},{"key":"2023060101575740300_hvad036-B14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1365-2125.2012.04406.x","article-title":"External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings","volume":"75","author":"Zhao","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"2023060101575740300_hvad036-B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/clinchem\/47.2.209","article-title":"Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose","volume":"47","author":"Boyd","year":"2001","journal-title":"Clin Chem"},{"key":"2023060101575740300_hvad036-B16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40262-018-0727-5","article-title":"Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations","volume":"58","author":"Colin","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"2023060101575740300_hvad036-B17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bcp.12444","article-title":"Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates","volume":"78","author":"Fuchs","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"2023060101575740300_hvad036-B18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11595640-000000000-00000","article-title":"Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance","volume":"51","author":"De Cock","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"2023060101575740300_hvad036-B19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11095-013-1197-y","article-title":"A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates","volume":"31","author":"De Cock","year":"2014","journal-title":"Pharm Res"},{"key":"2023060101575740300_hvad036-B20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1460-9592.2011.03534.x","article-title":"Predicting weight using postmenstrual age\u2013neonates to adults","volume":"21","author":"Sumpter","year":"2011","journal-title":"Pediatric Anesthesia"},{"key":"2023060101575740300_hvad036-B21","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1128\/AAC.00577-16","article-title":"Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants","volume":"60","author":"Germovsek","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060101575740300_hvad036-B22","year":"2013"},{"key":"2023060101575740300_hvad036-B23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jp.7210563","article-title":"Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs","volume":"21","author":"Al-Aweel","year":"2001","journal-title":"J Perinatol"},{"key":"2023060101575740300_hvad036-B24","author":"Australasian Neonatal Medicines Formulary"},{"key":"2023060101575740300_hvad036-B25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"2023060101575740300_hvad036-B26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s40264-019-00856-9","article-title":"Prevalence and nature of medication errors and preventable adverse drug events in paediatric and neonatal intensive care settings: a systematic review","volume":"42","author":"Alghamdi","year":"2019","journal-title":"Drug Saf"},{"key":"2023060101575740300_hvad036-B27","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1111\/bcp.14844","article-title":"Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions","volume":"87","author":"Roydhouse","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2023060101575740300_hvad036-B28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1542\/peds.77.6.848","article-title":"Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics","volume":"77","author":"Koren","year":"1986","journal-title":"Pediatrics"},{"key":"2023060101575740300_hvad036-B29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2042098617748868","article-title":"Interventions to reduce medication errors in neonatal care: a systematic review","volume":"9","author":"Nguyen","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"2023060101575740300_hvad036-B30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1309\/AJCPDSYS0DVLKFOH","article-title":"What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions","volume":"137","author":"Morrison","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2023060101575740300_hvad036-B31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11096-019-00886-4","article-title":"Optimising antimicrobial therapy through the use of Bayesian dosing programs","volume":"41","author":"Avent","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2023060101575740300_hvad036-B32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40262-015-0313-z","article-title":"Challenges associated with route of administration in neonatal drug delivery","volume":"55","author":"Linakis","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"2023060101575740300_hvad036-B33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/archdischild-2013-304887","article-title":"Intravenous drug delivery in neonates: lessons learnt","volume":"99","author":"Sherwin","year":"2014","journal-title":"Arch Dis Child"},{"key":"2023060101575740300_hvad036-B34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/phar.2279","article-title":"Falsely elevated vancomycin concentrations in a patient not receiving vancomycin","volume":"39","author":"Tsoi","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2023060101575740300_hvad036-B35","author":"US Department of Health & Human Services"},{"key":"2023060101575740300_hvad036-B36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinchem\/hvac070","article-title":"Improving harmonization and standardization of expanded newborn screening results by optimization of the legacy flow injection analysis tandem mass spectrometry methods and application of a standardized calibration approach","volume":"68","author":"Carling","year":"2022","journal-title":"Clin Chem"},{"key":"2023060101575740300_hvad036-B37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0067","article-title":"Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"53","author":"Sandberg","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2023060101575740300_hvad036-B38","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1515\/cclm-2015-0660","article-title":"Practical approach for medical validation of therapeutic drug monitoring results","volume":"54","author":"Oyaert","year":"2016","journal-title":"Clin Chem Lab Med"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/69\/6\/637\/50497830\/hvad036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/69\/6\/637\/50497830\/hvad036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:58:26Z","timestamp":1685584706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/69\/6\/637\/7146664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,28]]},"published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvad036","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,4,28]]}}}